论文部分内容阅读
本文采用数据包络分析方法(DEA),以我国2010年7月国家食品药品监督管理局南方医药经济研究所发布的“2009中国医药板块上市公司排行榜”的前五十名企业的核心竞争力数据为依据进行效率评价。
This article uses data envelopment analysis (DEA) to the core of the top 50 companies published by China Southern Pharmaceutical Economics Research Institute of the State Food and Drug Administration in July 2010, “2009 Ranking of Chinese Listed Companies in the Medical Sector” Competitiveness data as the basis for efficiency evaluation.